Skip to main content
CDC Website

Physicians

TB 101 para Trabajadores de la Salud

TB 101 for Health Care Workers is a web-based course designed to educate newly hired health care workers about basic concepts related to TB prevention and control in the U.S. Continuing education (CE) is offered free of charge for various professions based on approximately 1 hour of instruction. Upon successful completion of the course, exam, and evaluation, a CE certificate will be issued by CDC Training and Continuing Education Online. This course is also available in English.
Image:
Be The Generation Logo
Be The Generation
Date Created:
National Institutes of Health/NIAID
Be The Generation was created to promote awareness, understanding, and support for biomedical prevention research, including HIV vaccines, microbicides, pre-exposure prophylaxis research (PrEP) and treatment as prevention (TasP). The campaign was initiated under the National Institute of Allergy and...

Be The Generation

MMWR: Case Definitions for Infectious Conditions Under Public Health Surveillance

This report provides updated uniform criteria for use by public health professionals when reporting the nationally notifiable infectious diseases listed in Part One of this report. A revision date is included for case definitions that have been revised. The case definitions for some infectious conditions not designated as nationally notifiable are included in Part Two of this report.

Tuberculosis and AIDS

This report, for health professionals, government agencies, and organizations, presents information about HIV/AIDS and TB. It provides epidemiological statistics concerning the relationship between HIV/AIDS and TB, including incidence, morbidity rates, and mortality rates. It discusses TB and HIV transmission, how HIV can facilitate the development of active TB, and recommendations for the prevention of TB among HIV-positive persons.

MMWR: Clinical Update: Impact of HIV Protease Inhibitors on the Treatment of HIV - Infected Tuberculosis Patients With Rifampin

This report describes approaches for managing patients with TB who are candidates for or who are undergoing protease inhibitor therapy and presents interim recommendations for managing these patients until additional data are available and formal guidelines are issued. Protease inhibitors interact with rifamycin derivatives, which are used to treat and prevent the mycobacterial infections commonly observed in patients with the HIV. The report provides background information on the management of TB and the three treatment options currently available for these patients.

Increases in Unsafe Sex and Rectal Gonorrhea Among Men Who Have Sex With Men -- San Francisco, CA, 1994-1997

This journal discusses a range of issues related to STDs and HIV/AIDS. It analyzes a study that shows an increase in unprotected sex and rectal gonorrhea among gay men in San Francisco, CA. It provides statistical data from this study and discusses data collection methodology. The serial examines another study used to determine the frequency with which people get tested or are willing to be tested for HIV, and analyzes the results.

MMWR: Notice to Readers: Use of Short-Course Tuberculosis Preventive Therapy Regimens in HIV-Seronegative Persons

This report in the form of a notice to readers states that CDC in conjunction with the American Thoracic Society expects to issue new guidelines on screening and preventive therapy for TB that will include a recommendation on the use of the two-month regimen of daily rifampin and pyrazinamide (2RZ) as an alternative to 12-month isoniazid for prevention of TB in HIV-negative persons for whom preventive therapy is indicated. A comparative trial of the 2RZ regimen in HIV-negative persons has not been conducted.

MMWR: Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease

This report discusses the hepatitis C virus (HCV), how it is treated, and how it can be prevented. The report examines the epidemiology of HCV. It discusses the screening tests, history, general treatment, and postexposure prophylaxis for HCV. The report explains the ways that HCV can be transmitted from person to person and how the virus can be spread through bodily fluid. It identifies the most serious high risk behaviors such as injection drug use and certain sexual practices. The report cites the risks associated with health care work.

Policy Efforts to Increase IDUs' Access to Sterile Syringes

This information sheet explains that in order to reduce the transmission of HIV and other blood-borne infections, injecting drug users (IDUs), who cannot or will not stop injecting drugs, must have access to sterile syringes and injection equipment. However, many laws and regulations prohibit IDUs from purchasing these items. Some states have changed these laws and regulations and have seen positive results.